Dev

European Month of the Brain kicks off At the start of its European Month of the Brain, the European Commission has announced funding of around 150 million euros for 20 new international brain research projects, bringing the total European Union…

No firm evidence of benefit for any treatment or approach A systematic review has examined the best 32 randomised controlled trials (RCTs) investigating treatments for cognitive decline, including drug treatments, hormone therapies, nutritional supplements, physical activity and cognitive exercises. The authors…

Music effective for reducing anxiety and managing BPSD The authors of this study investigated the effects of music therapy on the Behavioral and Psychological Symptoms of Dementia (BPSD), cognitive function and activities of daily living in patients with dementia. Indications…

TED Talk by Neurosurgeon Andres Lozano In a recent TED talk, neurosurgeon Andres Lozano discusses recent developments in the potential uses of deep brain stimulation (DBS) for the alleviation of symptoms across many different neurological / neuropsychological conditions, including Parkinson’s…

The Michael J. Fox Foundation has launched a new arm of their Parkinson’s Progression Markers Initiative (PPMI), studying at-risk populations in Parkinson’s Disease The PPMI has completed enrollment of its initial 600-member cohort of Parkinson’s patients and controls, and is now…

A study of 20-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. A study – based on two cross-sectional surveys of people aged 75 years or over in Stockholm – explored whether the prevalence, survival, and incidence…

An integrated systems approach has identified genetic nodes and networks in late-onset Alzheimers Disease In the April 25 Cell, Valur Emilsson at the Icelandic Heart Association and Eric Schadt at Icahn School of Medicine at Mount Sinai, New York, report…

New compound that slows down the onset and progression of Parkinson’s disease in mice Research groups led by Armin Giese of LMU Munich and Christian Griesinger at the Max Planck Institute for Biophysical Chemistry in Göttingen have developed a chemical…

The two-year Joint Action on Alzheimer Cooperative Valuation in Europe recently published its recommendations The aim of the ALCOVE, (ALzheimer COoperative Valuation in Europe) project was to improve knowledge on dementia and its consequences, as well as promote the exchange…